Upload Image (Max 20MB per Image)
XBiotech has received FDA fast track designation for its anti-cachexia drug Xilonix, a first-in-class True Human antibody. Xilonix blocks an inflammatory substance (IL-1a) produced by the body in response to tumor growth, which plays a ...
Tags: XBiotech, fast track designation, anti-cachexia